Surmodics Narrows FY21 EPS Guidance From $0.10-$0.35 To $0.16-$0.31 Vs. $0.25 Est., Raises FY21 Sales Guidance From $101M-$105M To $103.5M-$105.5M Vs. $103.5M est.